---
figid: PMC6676106__CAS-110-2421-g006
figtitle: Proposed signaling pathway by which cysteine‐rich protein 61 (Cyr61) reduces
  imatinib mesylate (IM)‐induced CML cell apoptosis
organisms:
- NA
pmcid: PMC6676106
filename: CAS-110-2421-g006.jpg
figlink: /pmc/articles/PMC6676106/figure/cas14083-fig-0006/
number: F6
caption: Proposed signaling pathway by which cysteine‐rich protein 61 (Cyr61) reduces
  imatinib mesylate (IM)‐induced CML cell apoptosis. Increased Cyr61 in the bone marrow
  from CML patients stimulates nuclear factor kappa B (NF‐κB) phosphorylation, then
  upregulates Bcl‐2 production, finally leading to decrease of IM‐induced CML cell
  apoptosis and insensitivity to IM
papertitle: Cysteine‐rich protein 61 regulates the chemosensitivity of chronic myeloid
  leukemia to imatinib mesylate through the nuclear factor kappa B/Bcl‐2 pathway.
reftext: Yanfang Song, et al. Cancer Sci. 2019 Aug;110(8):2421-2430.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9074191
figid_alias: PMC6676106__F6
figtype: Figure
organisms_ner:
- Drosophila melanogaster
redirect_from: /figures/PMC6676106__F6
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6676106__CAS-110-2421-g006.html
  '@type': Dataset
  description: Proposed signaling pathway by which cysteine‐rich protein 61 (Cyr61)
    reduces imatinib mesylate (IM)‐induced CML cell apoptosis. Increased Cyr61 in
    the bone marrow from CML patients stimulates nuclear factor kappa B (NF‐κB) phosphorylation,
    then upregulates Bcl‐2 production, finally leading to decrease of IM‐induced CML
    cell apoptosis and insensitivity to IM
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - im
  - Debcl
  - Dif
  - dl
  - Rel
  - Chronic myelogenous leukemia
---
